🔎 Trials Near Me

ホーム › 心不全 › マサチューセッツ州 › Boston

Boston、MAにおける心不全の臨床試験

Bostonとその周辺地域(約30マイル以内)の拠点で、心不全に関する44件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

ELEVATE-HFpEF Clinical Study

被験者募集中
  • Tufts Medical Center, Boston
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

被験者募集中第3相
  • Research Site, Boston
18歳〜130歳 · 全性別 · 2026/10/02更新 · NCT06307652

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

被験者募集中観察研究健康なボランティア歓迎
  • Mass General Brigham, Boston
30歳以上 · 全性別 · 2026/09/29更新 · NCT06517186

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

被験者募集中観察研究健康なボランティア歓迎
  • Mass General Brigham, Boston
30歳以上 · 全性別 · 2026/09/29更新 · NCT05873634

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

被験者募集中第3相
  • Research Site, Boston
  • Research Site, Boston
18歳以上 · 全性別 · 2026/09/28更新 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

被験者募集中第3相
  • Tufts Medical Center, Boston
18歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06736574

Alleviant ALLAY-HFrEF Study

被験者募集中
  • Tufts Medical Center, Boston
  • Brigham and Women's Hospital, Boston
  • Boston Medical Center, Boston
18歳以上 · 全性別 · 2026/09/16更新 · NCT06812533

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

被験者募集中第3相
  • Research Site, Boston
40歳以上 · 全性別 · 2026/09/15更新 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

被験者募集中第3相
  • Boston, MA Investigative Stie 10087, Boston
18歳以上 · 全性別 · 2026/09/10更新 · NCT06008197

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

被験者募集中
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031

Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

被験者募集中
  • Massachusetts General Hospital, Boston
65歳以上 · 全性別 · 2026/09/01更新 · NCT05577819

Targeted Artificial Intelligence Language mOdel Recommendations for Heart Failure (TAILOR-HF)

被験者募集中
  • Mass General Brigham, Boston
18歳〜85歳 · 全性別 · 2026/08/31更新 · NCT07337577

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

被験者募集中観察研究健康なボランティア歓迎
  • Massachusetts General Hospital, Boston
18歳以上 · 全性別 · 2026/08/31更新 · NCT03480633

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

被験者募集中第2/3相
  • Boston Children's Hospital ( Site 0035), Boston
29 Days – 17 Years · 全性別 · 2026/08/28更新 · NCT05714085

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

被験者募集中第2相
  • Massachusetts General Hospital, Boston
40歳〜85歳 · 全性別 · 2026/08/27更新 · NCT06793371

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

被験者募集中観察研究
  • Research Site, Boston
18歳以上 · 全性別 · 2026/08/26更新 · NCT07690436

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

被験者募集中観察研究
  • Boston, Boston
全年齢 · 全性別 · 2026/08/20更新 · NCT00271180

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

被験者募集中観察研究
  • Harvard (Massachusetts General Hospital), Boston
  • Harvard Medical School - Brigham and Women's Hospital (BWH), Boston
18歳以上 · 全性別 · 2026/08/19更新 · NCT05489705

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

被験者募集中第3相
  • Tenax Investigational Site, Boston
18歳〜85歳 · 全性別 · 2026/08/19更新 · NCT07288398

Alleviant ALLAY-HF Study

被験者募集中
  • Brigham and Women's Hospital, Boston
  • Boston Medical Center, Boston
40歳以上 · 全性別 · 2026/08/14更新 · NCT05685303

OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

被験者募集中観察研究
  • Tufts Medical Center, Boston
18歳〜99歳 · 全性別 · 2026/08/11更新 · NCT06939751

Assessment of CCM in HF With Higher Ejection Fraction

被験者募集中
  • Massachusetts General Hospital, Boston
18歳以上 · 全性別 · 2026/08/06更新 · NCT05064709

Care Transitions App for Patients With Multiple Chronic Conditions

被験者募集中健康なボランティア歓迎
  • Brigham and Women's Hospital, Boston
55歳以上 · 全性別 · 2026/07/09更新 · NCT06051058

The STOP-MED CTRCD Trial

被験者募集中第4相
  • Brigham and Women's Hospital, Boston
18歳以上 · 全性別 · 2026/07/07更新 · NCT06183437

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

被験者募集中第3相
  • Boston Children's Hospital - Main Campus - Cardiology, Boston
18歳以下 · 全性別 · 2026/06/29更新 · NCT07192952

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

被験者募集中
  • Tufts Medical Center, Boston
  • Boston Medical Center Corporation, Boston
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

被験者募集中
  • Massachusetts General Hospital, Boston
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195

CCM OPEN HF Registry

被験者募集中観察研究
  • Massachusetts General Hospital, Boston
18歳以上 · 全性別 · 2026/04/23更新 · NCT07112924

Promoting Well-being and Health in Heart Failure

被験者募集中
  • Massachusetts General Hospital, Boston
18歳以上 · 全性別 · 2026/04/14更新 · NCT04829617

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

被験者募集中
  • St Elizabeth's Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess, Boston
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

被験者募集中第3相
  • Joslin Diabetes Center, Boston
18歳〜75歳 · 全性別 · 2026/03/24更新 · NCT06217302

Home Hospital for Suddenly Ill Adults

被験者募集中
  • Brigham and Women's Hospital, Boston
  • Brigham and Women's Faulkner Hospital, Boston
18歳以上 · 全性別 · 2026/03/17更新 · NCT03524222

Diffusion MRI in Heart Failure

被験者募集中早期第1相健康なボランティア歓迎
  • Massachusetts General Hospital, Charlestown · 1マイル先
18歳〜85歳 · 全性別 · 2025/12/24更新 · NCT02973633

A SkeleTal Muscle Recovery Intervention With Dietary Protein in Heart Failure

被験者募集中
  • Tufts Medical Center, Boston
18歳〜100歳 · 全性別 · 2025/11/25更新 · NCT05627440

Pulmonary Artery Catheter in Cardiogenic Shock Trial

被験者募集中
  • Tufts Medical Center, Boston
18歳〜90歳 · 全性別 · 2025/10/29更新 · NCT05485376

US Benchmarking Clinical Study

被験者募集中観察研究健康なボランティア歓迎
  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
  • Boston Medical Center, Boston
60歳以上 · 全性別 · 2025/10/20更新 · NCT07215715

Left vs Left Randomized Clinical Trial

被験者募集中
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
18歳以上 · 全性別 · 2025/10/02更新 · NCT05650658

Cardiogenic Shock Working Group Registry

被験者募集中観察研究
  • Tufts Medical Center, Boston
  • Beth Israel Deaconess Medical Center, Boston
18歳以上 · 全性別 · 2025/06/06更新 · NCT04682483

A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System

被験者募集中
  • One Boston Medical Center Place, Boston
22歳〜88歳 · 全性別 · 2025/05/30更新 · NCT06147336

Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure

被験者募集中観察研究
  • Tufts Medical Center, Boston
18歳〜100歳 · 全性別 · 2025/04/23更新 · NCT06253104

Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC

被験者募集中第1相
  • Brigham and Women's Hospital, Boston
18歳〜65歳 · 全性別 · 2025/02/06更新 · NCT06228924

他の都市における心不全の試験

Bostonにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。